Monolom India Pharma Private Limited - Company Profile

It is a pharma foreign private limited company based in Pune, Maharashtra, India, established in 2017.
2017 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Monolom India Pharma Private Limited

Monolom India Pharma Private Limited, a active foreign private limited company, was established on 27 October 2017 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24303PN2017FTC188118. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹5.30 Cr and a paid-up capital of ₹3.44 Cr.

It upholds a compliant status. Employing 39 professional, Its leadership includes Chiara Bergerone (Director), Ben Zion Dolitzky (Director), Ashutosh Vijay Joshi (Director). Past directors included Sumedha Nadkar Sanjeev, Barry Penney Wayne, Ravi Yadava. It holds ₹50.00 K open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.1-7&12-17,3 Floor,Genesis Square,Plot No.15 Intl Biotech Park,Midc Phase 2,Rg It Bt, Park,Maan, Pune, Maharashtra, 411057.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24303PN2017FTC188118

  • Registration Number

    188118

  • Incorporation Date

    27 October 2017

  • Authorized Capital

    ₹5.30 Cr

  • Paid-Up Capital

    ₹3.44 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.30 Cr
  • Paid Up Capital ₹ 3.44 Cr
  • Company Age 8 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 50.00 K
  • Revenue Growth **** 19.92%
  • Profit Growth **** 21.70%
  • Ebitda **** 1.58%
  • Net Worth 20.54%
  • Total Assets **** 7.16%
Company report

Monolom India Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Monolom India Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Monolom India Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Chiara Bergerone Director - Current
Ben Zion Dolitzky Director 24 Mar 2023 Current
Ashutosh Vijay Joshi Director 30 Jun 2025 Current
Adrien Aymery Joel Bresson Director 22 Jan 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Nov 2017 Past
Pramod Abcsdd Additional Director 19 May 2023 Past
Pramod Abcsdd Alternate Director 31 Dec 2020 Past
Pramod Abcsdd Additional Director 28 Sep 2023 Past
Pramod Abcsdd Director 29 Dec 2022 Past
Pramod Abcsdd Director 20 Nov 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Monolom India Pharma.

Monolom India Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.92% increase. The company also saw a substantial improvement in profitability, with a 21.7% increase in profit. The company's net worth Soared by an impressive increase of 20.54%.

Monolom India Pharma revenue growth over time
Monolom India Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 19.92%
*******
*******
*******
*******
Revenue from Operations
*******
 20.27%
*******
*******
*******
*******
Total Assets
*******
 7.16%
*******
*******
*******
*******
Profit or Loss
*******
 21.70%
*******
*******
*******
*******
Net Worth
*******
 20.54%
*******
*******
*******
*******
EBITDA
*******
 1.58%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Monolom India Pharma?

In 2023, Monolom India Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹50,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • The Hongkong And Shanghai Banking Corporation Limited : 0.01 Cr
Latest Charge Details
Date Lender Amount Status
23 Nov 2022 The Hongkong And Shanghai Banking Corporation Limited ₹0.05 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Monolom India Pharma?

Monolom India Pharma has a workforce of 39 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Monolom India Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Monolom India Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Monolom India Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Monolom India Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    Progress on Ashutosh Vijay Joshi was appointed as a Director was appointed as a Director on 30 Jun 2025 & has been associated with this company since 1 year 4 days . was documented.

  • Balance Sheet

    Progress on Monolom India Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Director Appointment

    Adrien Aymery Joel Bresson was appointed as a Director was appointed as a Director on 22 Jan 2025 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Charges

    Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 0.01 Cr registered on 23 Nov 2022 with Charge ID 100654549 was modified on 24 Jun 2024. was documented.

  • Director Appointment

    Progress on Ben Zion Dolitzky was appointed as a Director was appointed as a Director on 24 Mar 2023 & has been associated with this company since 3 years 3 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Monolom India Pharma Private Limited?

The CIN of Monolom India Pharma Private Limited is U24303PN2017FTC188118.

Where is Monolom India Pharma Private Limited headquartered?

Monolom India Pharma Private Limited is headquartered at No.1-7&12-17,3 Floor,Genesis Square,Plot No.15 Intl Biotech Park,Midc Phase 2,Rg It Bt, Park,Maan, Pune, Maharashtra, 411057.

When was Monolom India Pharma Private Limited incorporated?

Monolom India Pharma Private Limited was incorporated on 27 October 2017.

Who are the current directors of Monolom India Pharma Private Limited?

The current directors of Monolom India Pharma Private Limited are

What is the primary industry of Monolom India Pharma Private Limited?

The primary industry of Monolom India Pharma Private Limited is Professional, Scientific And Technical.

Is Monolom India Pharma Private Limited a listed company?

Monolom India Pharma Private Limited is unlisted.

What is the capital structure of Monolom India Pharma Private Limited?

The authorized capital of Monolom India Pharma Private Limited is ₹5.30 Cr, and the paid-up capital is ₹3.44 Cr.

What is the compliance status of Monolom India Pharma Private Limited?

The compliance status of Monolom India Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available